2023—2025年中国南部地区罗非鱼细菌病流行病学调查及格氏乳球菌的分离鉴定和致病性分析

Epidemiological investigation of bacterial diseases in Tilapia, and isolation, identification and pathogenicity analysis of Lactococcus garvieae in Southern China during 2023−2025

  • 摘要: 为探明2023—2025年罗非鱼主产区细菌性病原的流行特征,对广东、海南、云南、福建等中国南部地区的罗非鱼开展流行病学调查,以明确优势致病菌流行趋势、耐药特征及致病性,筛选敏感药物。结果显示,罗非鱼细菌病流行呈现显著地域差异。广东、海南地区以格氏乳球菌 (Lactococcus garvieae) 为主,分离率26.7%~100%,无乳链球菌 (Streptococcus agalactiae) 分离率0%~50%;福建、云南地区仍以无乳链球菌为优势菌,未检出格氏乳球菌。广东、海南发病罗非鱼典型症状为突眼、角膜白浊,下颌、鳃盖及鳍基出血,剖检可见肝脾肿大充血、肠道发炎、脑部充血等。经形态观察、生理生化鉴定及16S rRNA基因序列分析,确定优势菌为格氏乳球菌。药敏试验表明,分离菌呈多重耐药表征,对氟苯尼考、阿莫西林和多西环素等9种抗生素敏感,对磺胺类、喹诺酮类和氨基糖苷类等耐药率达60%以上。10株代表菌均携带hly、LPxTG-1—LPxTG-4、adh、adhPav、adhPsaA、adhCII等9种毒力相关基因。腹腔注射回归感染罗非鱼 (1×107 CFU·尾–1) 后,均出现自然发病相似症状,14 d累积死亡率为10%~50%。组织病理观察显示,感染鱼肝、脾、肾、鳃及脑等组织均出现特征性病理损伤。本研究明确了中国南部地区罗非鱼4个核心养殖省份中格氏乳球菌的流行趋势及耐药表征,解析其毒力基因携带谱及致病性,为该病原的诊断与精准防控提供了科学依据。

     

    Abstract: To investigate the epidemiological characteristics of bacterial pathogens in tilapia (Oreochromis ) aquaculture from 2023 to 2025, we conducted a survey in tilapia-farming regions across southern China, including Guangdong, Hainan, Yunnan, and Fujian Provinces, thus clarifying the prevalence dynamics, antimicrobial resistance profiles and pathogenicity of dominant pathogens, and screening for sensitive antibiotics. The results showed significant regional differences in bacterial diseases: Lactococcus garvieae is the predominant pathogen in Guangdong and Hainan (Isolation rates: 26.7% to 100%), while Streptococcus agalactiae isolation rates ranged from 0% to 50%; S. agalactiae remained dominant in Fujian and Yunnan, where L. garvieae was not detected. Clinical signs in diseased tilapia from Guangdong and Hainan included exophthalmia, corneal opacity, and hemorrhage in the lower jaw, operculum, and fin bases. Necropsy revealed hepatosplenomegaly and congestion, intestinal inflammation, and cerebral congestion. Morphological, physiological and biochemical, and 16S rRNA gene sequence analysis confirmed the dominant pathogen as L. garvieae. Antimicrobial susceptibility tests indicated that the isolates exhibited obvious multidrug-resistant phenotypes. They were sensitive to nine antibiotics (e.g. florfenicol, amoxicillin, doxycycline), while the resistance rates to sulfisoxazole, quinolones, and enrofloxacin exceed 60%. Ten representative L. garvieae strains carried nine virulence genes: hly, LPxTG-1–LPxTG-4, adh, adhPav, adhPsaA, and adhCII. After intraperitoneal injection with L. garvieae (1×107 CFU·tail–1), challenged tilapia exhibited symptoms similar to natural infections, with cumulative mortality rates of 10% to 50% over 14 d; histopathological observation showed characteristic damage in the liver, spleen, kidney, gills, and brain. This study clarifies the prevalence trends and multidrug-resistant characteristics of L. garvieae in four major tilapia-farming regions of southern China, analyzes its virulence genes and pathogenicity, and provides a scientific basis for the diagnosis and control.

     

/

返回文章
返回